Core MRI technology provides most advanced scanners for highest
intraoperative image quality and best workflow available
MINNEAPOLIS, July 23, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that the Company has
obtained regulatory CE mark for integrating the next generation MRI
core technology into the VISIUS® Surgical Theatre allowing for sales and marketing in the European
This newest imaging technology, based on the Siemens Aera 1.5T(tesla)
and Skyra 3.0T MRI scanners, helps IMRIS deliver even better image
quality, faster 3D image acquisition, and improved ease-of-use and
workflow during surgical procedures using intraoperative MRI (iMRI).
The Company received United States Food and Drug Administration (FDA)
approval for these advancements in February 2014.
"These high-field intraoperative scanner options will give a hospital's
clinical team state-of-the-art applications and image quality that
increase productivity," said IMRIS President and CEO Jay D. Miller. "We
bring the latest and unequaled imaging technology into the operating
room where it can make the most difference - during the surgery. More
and more neurosurgical centers are using image guidance with VISIUS
iMRI for an expanding list of conditions and procedures and adjunctive
interventions beyond brain tumor resections, such as laser ablation for
tumors and epilepsy using stereotactic tools, deep brain stimulation
(DBS) and other minimally-invasive techniques that are designed to
improve patient outcomes."
Inside a VISIUS Surgical Theatre equipped with high-field iMRI, surgeons
have on-demand access to real-time data and state-of-the-art imaging
during the procedure as the scanner uniquely moves on ceiling-mounted
rails. The Company also designs and manufactures proprietary
intraoperative CTs, head fixation devices, imaging coils, and OR tables
for use in this unique and multifunctional intraoperative environment.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 58 leading medical
institutions around the world.
Image with caption: "The IMRIS VISIUS Surgical Theatre with intraoperative MRI (iMRI) has received CE mark for European distribution for including Siemens Aera and Skyra MR technology. This provides neurosurgeons using the system with the most advanced MR scanners for the highest intraoperative image quality and workflow in an operating room. (CNW Group/IMRIS Inc.)". Image available at: http://photos.newswire.ca/images/download/20140723_C8482_PHOTO_EN_42224.jpg
SOURCE: IMRIS Inc.
For further information:
Kevin J. Berger
Marketing Communications Manager